Bhatia Sangeeta N. bought VRTX
May 1, 2026 · Form 4 insider transaction
Bhatia Sangeeta N. bought 943 shares of Vertex Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
943
Price
$0.00
Total value
N/A
InsiderBhatia Sangeeta N.
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 1, 2026
Filing dateMay 5, 2026
Shares owned after5,242
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.